A New, Rapid, Fully Automated Method for Determination of Fluconazole in Serum by Column-Switching Liquid Chromatography
暂无分享,去创建一个
[1] M. Ehrlich,et al. New and rapid fully automated method for determination of tazobactam and piperacillin in fatty tissue and serum by column-switching liquid chromatography. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[2] L. Decosterd,et al. Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography. , 2002, Journal of pharmaceutical and biomedical analysis.
[3] M. Ghannoum,et al. Antifungal Susceptibility Testing: Practical Aspects and Current Challenges , 2001, Clinical Microbiology Reviews.
[4] M. Ehrlich,et al. A new and rapid method for monitoring the new oxazolidinone antibiotic linezolid in serum and urine by high performance liquid chromatography-integrated sample preparation. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[5] D. Sanglard,et al. Sensitive Bioassay for Determination of Fluconazole Concentrations in Plasma Using a Candida albicans Mutant Hypersusceptible to Azoles , 2001, Antimicrobial Agents and Chemotherapy.
[6] Y. Kanda,et al. Serum levels of fluconazole in patients after cytotoxic chemotherapy for hematological malignancy , 2001, American journal of hematology.
[7] M. Ehrlich,et al. Rapid antibiotic drug monitoring: meropenem and ceftazidime determination in serum and bronchial secretions by high-performance liquid chromatography-integrated sample preparation. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[8] M. Takada,et al. Fluconazole-Induced Convulsions at Serum Trough Concentrations of Approximately 80 &mgr;g/mL , 2000, Therapeutic drug monitoring.
[9] M. Jemal,et al. Direct injection versus liquid-liquid extraction for plasma sample analysis by high performance liquid chromatography with tandem mass spectrometry. , 1999, Rapid communications in mass spectrometry : RCM.
[10] G. Corso,et al. Fluconazole bioequivalence study: quantification by tandem mass spectrometry. , 1999, Therapeutic drug monitoring.
[11] A. Penk,et al. Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD) , 1999, Mycoses.
[12] J. Faucher,et al. Unusual outcome of disseminated candidiasis treated with fluconazole: a matter of pharmacokinetics? , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] A. Penk,et al. [Pharmacokinetics and dosage of fluconazole in continuous hemofiltration (CAVH, CVVH) and hemodialysis (CAVHD, CVVHD)]. , 1998, Mycoses.
[14] J. Graybill,et al. Therapeutic drug monitoring of systemic antifungal therapy. , 1997, The Journal of antimicrobial chemotherapy.
[15] W. Hurford,et al. Fluconazole Serum Concentrations and Pharmacokinetics in an Obese Patient , 1997, Pharmacotherapy.
[16] D. Spence,et al. Variability of plasma fluconazole levels in patients with hematologic malignancy. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] F. Bressolle,et al. High-performance liquid chromatographic determination of fluconazole in plasma. , 1996, Journal of chromatography. B, Biomedical applications.
[18] F. von Heeren,et al. Determination of fluconazole in human plasma by micellar electrokinetic capillary chromatography with detection at 190 nm. , 1996, Journal of chromatography. A.
[19] H. Dermoumi,et al. Serum level determination of fluconazole by high-performance liquid chromatography and bioassay. , 1996, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[20] H. Rosing,et al. High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients. , 1995, Journal of chromatography. B, Biomedical applications.
[21] D. Lubda,et al. Alkyl-Diol Silica (ADS): restricted access precolumn packings for direct injection and coupled-column chromatography of biofluids , 1995 .
[22] F. Flores-Murrieta,et al. A Simple and Rapid Method for Determination of Fluconazole in Human Plasma Samples by High-Performance Liquid Chromatography , 1994 .
[23] J. Böhler,et al. Drug Dosage in Patients during Continuous Renal Replacement Therapy , 1993, Clinical pharmacokinetics.
[24] D. Debruyne,et al. Clinical Pharmacokinetics of Fluconazole , 1993, Clinical pharmacokinetics.
[25] M. Gill,et al. Determination of fluconazole in human serum by solid-phase extraction and reversed-phase high-performance liquid chromatography. , 1992, Therapeutic drug monitoring.
[26] M. Rinaldi,et al. Assay of fluconazole by high-performance liquid chromatography with a mixed-phase column , 1992, Antimicrobial Agents and Chemotherapy.
[27] D. Stevens,et al. Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography , 1991, Antimicrobial Agents and Chemotherapy.
[28] M. Gardner,et al. Induction of Fluconazole Metabolism by Rifampin: In Vivo Study in Humans , 1991, Journal of clinical pharmacology.
[29] I. Yoshiya,et al. Rapid determination of serum levels of a new antifungal agent, fluconazole, by high-performance liquid chromatography. , 1990, Journal of chromatography.
[30] O. Zee,et al. A sensitive and simplified HPLC analysis for the determination of fluconazol in human plasma , 1988 .